DIRECT COSTS OF PATIENTS WITH GLAUCOMA AT THE DIXPANSE OUTPATIENT CLINIC, DEPARTMENT OF GLAUCOMA, VIETNAM NATIONAL EYE HOSPITAL, 2026
Main Article Content
Abstract
Vietnam National Eye Hospital is a leading specialist hospital providing treatment and long-term follow-up care for many patients with Glaucoma. This study was to describe the direct costs among patients with Glaucoma receiving follow-up care at the Dispensary Clinic, Department of Glaucoma, Vietnam National Eye Hospital, in 2026. A descriptive cross-sectional study was conducted, combining direct medical costs of 312 patients from retrospective hospital data and direct non-medical costs from a survey using a semi-structured questionnaire. The mean total direct costs of the most recent inpatient and outpatient treatment episodes were VND 4581799.18 and VND 2588581.33 per patient, respectively. Hospital bed charges accounted for the largest share of inpatient direct medical costs (35.20%), whereas medications accounted for the largest share of outpatient direct medical costs (71.78%). Health insurance covered 84.41% of inpatient direct medical costs but only 11.23% of outpatient direct medical costs. Transportation cost accounted for 74.98% of outpatient direct non-medical costs.
Keywords
Direct costs, Glaucoma, Vietnam National Eye Hospital.
Article Details
References
[2] Đỗ Như Hơn .(2014). Nhãn khoa tập 3. Nhà xuất bản Y học. 2014;
[3]. Lê Thị Khánh Châu (2020). Phân tích chi phí điều trị ngoại trú bệnh glôcôm giai đoạn 2017-2019 và glôcôm góc mở năm 2020 tại Bệnh viện Mắt thành phố Hồ Chí Minh. Luận văn chuyên khoa cấp II, Đại Học Y Dược Thành Phố Hồ Chí Minh. 2020;
[4]. Lorenz K, Wolfram C, Breitscheidel L, Shlaen M, Verboven Y, Pfeiffer N. (2013) Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany. Graefe's archive for clinical and experimental ophthalmology. Aug 2013;251(8):2019-28. DOI:10.1007/s00417-013-2354-z
[5]. Meier-Gibbons F, Töteberg-Harms M. Influence of Cost of Care and Adherence in Glaucoma Management: An Update. (2020) J Ophthalmol.2020:5901537. DOI:10.1155/2020/5901537
[6]. Ministry of Health, Medical Service Administration. (2025). National Survey on Avoidable Blindness Viet Nam, 2015: Using the Rapid Assessment for Avoidable Blindness (RAAB) methodology. Hanoi: Ministry of Health; 2015. p. 9.
[7]. Rahman M. Q, Beard S. M, Discombe R, Sharma R, Montgomery D. M. Direct healthcare costs of glaucoma treatment. (2013). The British journal of ophthalmology. Jun 2013;97(6):720-4. doi:10.1136/bjophthalmol-2012-302525
[8]. Shih Vanessa, Parekh Mousam, Multani Jasjit K, et al.(2021). Clinical and economic burden of glaucoma by disease severity: a United States claims-based analysis. Ophthalmology Glaucoma. 2021;4(5):490-503. DOI: 10.1016/j.ogla.2020.12.007
[9]. Traverso C. E, Walt J. G, Kelly S. P, et al. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. (2005). The British journal of ophthalmology. Oct 2005;89(10):1245-9. doi:10.1136/bjo.2005.067355
[10]. Trần Quang Khải. (2022). Phân tích chi phí điều trị nội trú bệnh glaucoma góc đóng năm 2022 tại Bệnh viện Mắt thành phố Hồ Chí Minh. Luận văn thạc sĩ Dược hoc - Đại học y dược thành phố Hồ Chí Minh. 2022;
[11]. World Health Organization. (2019) World report on vision. WHO 2019:11.